BioLineRx Ltd. (BLRX) stock
BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 3/30
$1.12−0.03 (-2.61%)
Close on Nov 17, 2026Market cap $4.87MP/E –Yield –
BioLineRx enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
BioLineRx's enterprise value was $8.82M on Nov 11, 2026, against $4.22M a year earlier. Over the last 5 years it ranged from -$578.21K to $86.88M, with a median of $20.26M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $8.82M | +212.7% |
| 2025 | Dec 31, 2025 | $2.82M | -80.9% |
| 2024 | Dec 31, 2024 | $14.78M | -80.0% |
| 2023 | Dec 29, 2023 | $73.98M | +465.2% |
| 2022 | Dec 30, 2022 | $13.09M | -35.4% |
| 2021 | Dec 31, 2021 | $20.26M | -7.7% |
| 2020 | Dec 31, 2020 | $21.94M | +60.0% |
| 2019 | Dec 31, 2019 | $13.71M | -59.2% |
| 2018 | Dec 31, 2018 | $33.65M | -42.8% |
| 2017 | Dec 29, 2017 | $58.82M | +40.9% |
| 2016 | Dec 30, 2016 | $41.75M | – |
See a number that looks wrong?